Company intelligence / Profile preview

Dosis

San Francisco, California, United States
Ownership
Private
Employees
~25
Development stage
Other
01

Overview

Dosis is a private healthcare software company focused on AI-enabled precision dosing and clinical decision support for chronic disease management. Its lead commercial product, Strategic Anemia Advisor, helps dialysis providers personalize erythropoiesis-stimulating agent dosing for patients with chronic anemia, particularly in chronic kidney disease settings. The company also launched Strategic Iron Advisor to support individualized intravenous iron dosing as part of anemia management. Dosis positions its technology as a way to improve patient outcomes, increase safety, and reduce unnecessary drug utilization and cost for providers. The business operates at the intersection of precision medicine, nephrology, and healthcare AI rather than as a therapeutic drug developer.

Therapeutic areas
HematologyNephrology
Modalities
SoftwareArtificial intelligence
Industry
Digital Health Medical Devices

Beyond the preview

Go deeper on Dosis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dosis.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call